遵义医科大学附属医院神经内科,贵州,遵义,563000
师利敏,第一作者,研究方向:认知功能障碍,E-mail:shilimin_97@163.com
纸质出版日期:2024-01-20,
收稿日期:2023-09-10,
录用日期:2023-12-01
扫 描 看 全 文
师利敏,徐平.髓系细胞触发受体2在认知功能障碍中相关机制的研究进展[J].中山大学学报(医学科学版),2024,45(01):7-12.
SHI Limin,XU Ping.Research Progress on Mechanisms of Triggeringreceptor Expressed on Myeloid Cells-2 in Cognitive Dysfunction[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(01):7-12.
师利敏,徐平.髓系细胞触发受体2在认知功能障碍中相关机制的研究进展[J].中山大学学报(医学科学版),2024,45(01):7-12. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20240004.018.
SHI Limin,XU Ping.Research Progress on Mechanisms of Triggeringreceptor Expressed on Myeloid Cells-2 in Cognitive Dysfunction[J].Journal of Sun Yat-sen University(Medical Sciences),2024,45(01):7-12. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20240004.018.
神经免疫系统对中枢神经系统的发育、衰老和损伤至关重要,逐渐成为人们研究的热点。髓系细胞触发受体2(TREM2)是免疫球蛋白超家族的一种跨膜受体,在中枢神经系统中主要表达于小胶质细胞。越来越多的研究表明,靶向TREM2对改善阿尔兹海默症、血管性痴呆、帕金森病、术后认知功能障碍、肥胖等疾病相关的认知功能障碍有很大的潜力。然而,其在认知功能障碍中的具体作用尚缺乏系统性的总结。故本文综述了TREM2在认知功能障碍中相关机制的最新研究进展,以期为认知功能障碍的治疗提供新的靶点。
The neuroimmune system is crucial for the development, aging, and damage of the central nervous system, and has gradually become a research hotspot. Triggeringreceptor expressed on myeloid cells-2 (TREM2) is a transmembrane receptor of the immunoglobulin superfamily and is mainly expressed in the microglia in the central nervous system. An increasing number of studies indicate that TREM2 has great potential to improve cognitive dysfunction related to Alzheimer's disease, vascular dementia, Parkinson's disease, postoperative cognitive impairment, obesity, etc. However, there is a lack of a systematic summary of the specific role of TREM2 in cognitive dysfunction. This paper reviews the progress in the latest research on the related mechanisms of TREM2 in cognitive dysfunction, in order to provide new strategies for the treatment of cognitive dysfunction.
认知功能障碍TREM2阿尔茨海默病血管性痴呆帕金森病术后认知功能障碍肥胖
cognitive dysfunctiontriggeringreceptor expressed on myeloid cells-2 (TREM2)Alzheimer's diseasevascular dementiaParkinson's diseasepostoperative cognitive impairmentobesity
World Health Organization. Global status report on the public health response to dementia:executive summary[EB/OL].(2021-09-01)[2023-07-21].https://www.who.int/publications/i/item/9789240033245https://www.who.int/publications/i/item/9789240033245
World Health Organization. Global action plan to address dementia in the public health sector[EB/OL].(2017-12-08)[2023-07-21]. https://www.who.int/publications/i/item/9789241513487https://www.who.int/publications/i/item/9789241513487
Bianchin MM, Lima JE, Natel J,et al. The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2[J]. Neurology, 2006, 66(4): 615-616.
Jonsson T, Stefansson H, Steinberg S, et al. Variant of TREM2 associated with the risk of alzheimer's disease [J]. N Engl J Med, 2013, 368(2): 107-116.
Deczkowska A, Weiner A, Amit I. The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway [J]. Cell, 2020, 181(6):1207-1217.
Kober D L, Brett T J. TREM2-ligand interactions in health and disease[J]. J Mol Biol, 2017, 429(11): 1607-1629.
Cui X, Qiao J, Liu S, et al. Mechanism of TREM2/DAP12 complex affecting β-amyloid plaque deposition in alzheimer's disease modeled mice through mediating inflammatory response[J]. Brain Res Bull, 2021, 166: 21-28.
Iizasa E, Chuma Y, Uematsu T, et al. TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation[J]. Nat Commun, 2021, 12(1): 2299.
Ju Y H, Bhalla M, Hyeon SJ, et al. Astrocytic urea cycle detoxifies Aβ-derived ammonia while impairing memory in alzheimer's disease [J]. Cell Metab, 2022, 34(8): 1104-1120.
牛波, 王欣怡, 徐江平, 等. β-淀粉样蛋白对叉头蛋白O3a和突触后致密蛋白95的影响[J]. 中山大学学报(医学科学版), 2021,42(5):676-685.
Niu B, Wang XY, Xu JP, et al. Effects of β-amyloid on the expression of forkhead protein o3a and postsynaptic density protein 95[J]. J Sun Yat-sen Univ (Med Sci), 2021, 42(5):676-685.
Ren X, Yao L Wang, Y, et al. Microglial VPS35 deficiency impairs Aβ phagocytosis and Aβ-induced disease-associated microglia, and enhances Aβ associated pathology[J]. J Neuroinflammation, 2022, 19(1): 61.
Wang Y, Cella M, Mallinson K, et al. TREM2 lipid sensing sustains the microglial response in an alzheimer's disease model [J]. Cell, 2015, 160(6): 1061-1071.
Bhattacherjee A, Jung J, Zai S, et al. The CD33 short isoform is a gain-of-function variant that enhances Aβ(1-42) phagocytosis in microglia [J]. Mol Neurodegener, 2021, 16(1): 19.
Griciuc A, Patlel S, Federico A N, et al. TREM2 acts downstream of CD33 in modulating microglial pathology in alzheimer's disease [J]. Neuron, 2019, 103(5): 820-835.
Buée L, Bussière T, Buée-Scherrer V, et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders [J]. Brain Res Brain Res Rev, 2000, 33(1): 95-130.
Gratuze M, Chen Y, Parhizkr S, et al. Activated microglia mitigate Aβ-associated tau seeding and spreading [J]. J Exp Med, 2021, 218(8): e20210542.
Zhu B, Liu Y, Hwang S, et al. Trem2 deletion enhances tau dispersion and pathology through microglia exosomes[J]. Mol Neurodegener, 2022, 17(1): 58.
Jackson L, DIumanl S, JOHNSON M H, et al. Microglia knockdown reduces inflammation and preserves cognition in diabetic animals after experimental stroke[J].J Neuroinflammation, 2020, 17(1): 137.
刘纯飞,徐平.电压依赖性阴离子通道1介导的炎症与睡眠呼吸暂停综合征[J]. 中山大学学报(医学科学版),2023,44(5):735-740.
Liu CF,Xu P.Voltage Dependent Anion Channel 1 Mediated Inflammation and Obstructive Sleep Apnea Syndrome[J].J Sun Yat-Sen Univ(Med Sci),2023,44(5):735-740.
Kinney JW, Bemiller SM, Murtishaw AS, et al. Inflammation as a central mechanism in alzheimer's disease [J]. Alzheimers Dement (N Y), 2018, 4: 575-590.
Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration [J]. Annu Rev Immunol, 2017, 35:441-468.
Zhang L, Liu Y, Wang X, et al. Treadmill exercise improve recognition memory by TREM2 pathway to inhibit hippocampal microglial activation and neuroinflammation in alzheimer's disease model[J]. Physiol Behav, 2022, 251:113820.
Ruganzu J B, Zheng Q, Wu X, et al. TREM2 overexpression rescues cognitive deficits in APP/PS1 transgenic mice by reducing neuroinflammation via the JAK/STAT/SOCS signaling pathway[J]. Exp Neurol, 2021, 336: 113506.
Wang Y, Lin Y, Wang L, et al. TREM2 ameliorates neuroinflammatory response and cognitive impairment via PI3K/AKT/FoxO3a signaling pathway in alzheimer's disease mice[J]. Aging (Albany NY), 2020, 12(20): 20862-20879.
Wu Y, Dissing-olesen L, Macvicar B A, et al. Microglia: dynamic mediators of synapse development and plasticity[J]. Trends Immunol, 2015, 36(10): 605-613.
Riccomagno MM, Kolodkin A L. Sculpting neural circuits by axon and dendrite pruning[J]. Annu Rev Cell Dev Biol, 2015, 31: 779-805.
Filipello F, Morini R, Corradini L, et al. The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity[J]. Immunity, 2018, 48(5): 979-991.
Qin Q, Wang M, Yin Y, et al. The specific mechanism of TREM2 regulation of synaptic clearance in alzheimer's disease[J]. Front Immunol, 2022, 13: 845897.
Rajendran L, Paolicell RC. Microglia-mediated synapse loss in alzheimer's disease[J]. J Neurosci, 2018, 38(12): 2911-2919.
Sheng L, Chen M, Cai K, et al. Microglial TREM2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice[J]. FASEB J, 2019, 33(9): 10425-10442.
Zhao P, Xu Y, Jiang L, et al. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of alzheimer's disease[J]. Sci Transl Med, 2022, 14(661): eabq0095.
Wang S, Mustafa M, Yuedeue C M, et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an alzheimer's disease model[J]. J Exp Med,2020, 217(9): e20200785.
Xu Y, Wang Q, Cui R, et al. Uric acid is associated with vascular dementia in chinese population [J]. Brain Behav, 2016, 7(2): e00617.
Wang Q, Yang W, Zhang J, et al. TREM2 overexpression attenuates cognitive deficits in experimental models of vascular dementia[J]. Neural Plast, 2020: 8834275.
Zhang J, Liu Y, Zheng Y, et al. TREM-2-p38 MAPK signaling regulates neuroinflammation during chronic cerebral hypoperfusion combined with diabetes mellitus[J]. J Neuroinflammation, 2020, 17(1): 2.
郑亚玲,刘雨,张嘉维,等.姜黄素调控TREM2-TLR4对糖尿病慢性脑低灌注模型大鼠认知功能的保护作用[J].中国临床神经科学,2020,28(4):371-378.
Zheng YL, Liu Y, Zhang JW, et al. Protective effect of curcumin regulating TREM2-TLR4 on cognitive function in chronic cerebral hypoperfusion model rats with diabetes[J]. Chin J Clin Neuros, 2020, 28(4):371-378.
Anand SS, Friedrich MG, Lee DS, et al. Evaluation of adiposity and cognitive function in adults[J]. JAMA Netw Open, 2022, 5(2): e2146324.
Wu M, Liao M, Huang R, et al. Hippocampal overexpression of TREM2 ameliorates high fat diet induced cognitive impairment and modulates phenotypic polarization of the microglia[J]. Genes Dis, 2022, 9(2): 401-414.
Celilbil A, Celikbil M, Bozkurt G. Cognitive assessment of patients with nonalcoholic fatty liver disease[J]. Eur J Gastroenterol Hepatol, 2018, 30(8): 944-950.
Ga XR, Chen Z, Fang K, et al. Protective effect of quercetin against the metabolic dysfunction of glucose and lipids and its associated learning and memory impairments in NAFLD rats[J]. Lipids Health Dis, 2021, 20(1): 164.
Lin D, Zhang H, Zhang J, et al. Huang K, Chen Y, Jing X, Tao E. α-Synuclein induces neuroinflammation injury through the IL6ST-AS/STAT3/HIF-1α Axis. [J]. Int J Mol Sci. 2023, 24(2):1436.
Hung LW, Villemagne VL, Cheng L, et al. The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of parkinson's disease[J]. Exp Med, 2012, 209(4): 837-54.
Guo Y, Wei X, Yan H, et al. TREM2 deficiency aggravates α-synuclein-induced neurodegeneration and neuroinflammation in parkinson's disease models[J]. FASEB J, 2019, 33(11): 12164-12174.
杨熔,徐凯飞,张锋.二氢槲皮素激活小胶质细胞TREM2保护6-OHDA诱导的多巴胺神经元损伤[J].中国药理学与毒理学杂志,2023,37(7):522.
Yang R, Xu KF, Zhang F, et al. Dihydroquercetin activates TREM2 in microglia to protect 6-OHDA induced dopamine neuron damage[J]. Chin J Pharm Toxicol, 2023, 37(7):522.
Jiang W, Liu F, Li H, et al. TREM2 ameliorates anesthesia and surgery-induced cognitive impairment by regulating mitophagy and NLRP3 inflammasome in aged C57/BL6 mice[J]. Neurotoxicology, 2022, 90: 216-227.
Han X, Cheng X, Xu J, et al. Activation of TREM2 attenuates neuroinflammation via PI3K/Akt signaling pathway to improve postoperative cognitive dysfunction in mice[J]. Neuropharmacology, 2022, 219: 109231.
Qu W, Li L. Loss of TREM2 confers resilience to synaptic and cognitive impairment in aged mice [J]. J Neurosci, 2020, 40(50): 9552-9563.
Wei MD, Lan YX, Lu K, et al. Knockdown of astrocytic TREM2 in the hippocampus relieves cognitive decline in elderly male mice[J]. Behav Brain Res, 2021, 397: 112939.
0
浏览量
17
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构